StockNews.com began coverage on shares of Jaguar Health (NASDAQ:JAGX – Free Report) in a research report report published on Monday. The firm issued a sell rating on the biotechnology company’s stock.
Jaguar Health Stock Performance
Shares of NASDAQ:JAGX opened at $0.17 on Monday. The business’s fifty day moving average price is $0.09 and its two-hundred day moving average price is $0.18. The company has a current ratio of 2.00, a quick ratio of 1.34 and a debt-to-equity ratio of 6.33. Jaguar Health has a one year low of $0.05 and a one year high of $1.22.
About Jaguar Health
See Also
- Five stocks we like better than Jaguar Health
- Canadian Penny Stocks: Can They Make You Rich?
- Hasbro’s Management Made All the Right Calls This Quarter
- P/E Ratio Calculation: How to Assess Stocks
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.